Suppr超能文献

异基因造血干细胞移植受者中针对碳青霉烯类耐药肠杆菌科定植的串联粪便微生物移植周期:一例病例报告及文献复习。

Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.

机构信息

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China.

Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.

出版信息

Eur J Med Res. 2021 Apr 28;26(1):37. doi: 10.1186/s40001-021-00508-8.

Abstract

BACKGROUND

Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high non-relapse mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Also, intestinal CRE colonization is a risk factor for subsequent CRE infection. Several clinical studies have reported successful fecal microbiota transplantation (FMT) for the gut decontamination of a variety of multidrug-resistant bacteria (MDRB), even in immunosuppressed patients. Similarly, other studies have also indicated that multiple FMTs may increase or lead to successful therapeutic outcomes.

CASE PRESENTATION

We report CRE colonization in an allo-HSCT patient with recurrent CRE infections, and its successful eradication using tandem FMT cycles at 488 days after allo-HSCT. We also performed a comprehensive microbiota analysis. No acute or delayed adverse events (AEs) were observed. The patient remained clinically stable with CRE-negative stool culture at 26-month follow-up. Our analyses also showed some gut microbiota reconstruction. We also reviewed the current literature on decolonization strategies for CRE.

CONCLUSIONS

CRE colonization led to a high no-relapse mortality after allo-HSCT; however, well-established decolonization strategies are currently lacking. The successful decolonization of this patient suggests that multiple FMT cycles may be potential options for CRE decolonization.

摘要

背景

由于抗生素选择有限,碳青霉烯类耐药肠杆菌科(CRE)感染与异基因造血干细胞移植(allo-HSCT)后非复发死亡率高有关。此外,肠道 CRE 定植是随后发生 CRE 感染的危险因素。几项临床研究报告了粪便微生物群移植(FMT)在多种多药耐药菌(MDRB)肠道去污染方面的成功应用,即使在免疫抑制患者中也是如此。同样,其他研究也表明,多次 FMT 可能会增加或导致成功的治疗结果。

病例介绍

我们报告了一例 allo-HSCT 患者在 allo-HSCT 后 488 天出现复发性 CRE 感染和 CRE 定植,使用串联 FMT 周期成功清除。我们还进行了全面的微生物组分析。未观察到急性或迟发性不良事件(AE)。在 26 个月的随访中,患者仍保持临床稳定,CRE 粪便培养阴性。我们的分析还显示了一些肠道微生物组的重建。我们还回顾了目前关于 CRE 去定植策略的文献。

结论

allo-HSCT 后 CRE 定植导致非复发死亡率高;然而,目前缺乏成熟的去定植策略。该患者成功去定植表明,多次 FMT 周期可能是 CRE 去定植的潜在选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/820851de2b41/40001_2021_508_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验